PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Cancer 1,053,491 Disease Target Glutathione Peroxidase 2 67 16 0.00 -0.87 0.24 0.56
Cancer 1,053,491 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Cancer 1,053,491 Disease Disease Carcinoma Prostate 68 27 0.00 -0.78 0.40 0.57
Cancer 1,053,491 Disease Target ARAP 68 3 0.00 -0.98 0.04 0.53
Cancer 1,053,491 Disease Target Glutathione S-Transferase Theta-1 70 22 0.00 -0.83 0.31 0.57
Cancer 1,053,491 Disease Drug 4-Mercaptobenzoic Acid 70 4 0.00 -0.97 0.06 0.53
Cancer 1,053,491 Disease Target Opioid Receptor Mu 71 1 0.00 -0.99 0.01 0.51
Cancer 1,053,491 Disease Drug Aripiprazole (Abilify)- FDA 71 1 0.00 -0.99 0.01 0.51
Cancer 1,053,491 Disease Target Microtubule-Associated Protein 1a 73 3 0.00 -0.98 0.04 0.53
Cancer 1,053,491 Disease Target CD148 74 3 0.00 -0.98 0.04 0.53
Cancer 1,053,491 Disease Target CXCL7 76 12 0.00 -0.92 0.16 0.55
Cancer 1,053,491 Disease Target Actin beta 76 4 0.00 -0.97 0.05 0.53
Cancer 1,053,491 Disease Drug Drotaverine 76 1 0.00 -0.99 0.01 0.50
Cancer 1,053,491 Disease Target Neuropeptide S Receptor 77 2 0.00 -0.99 0.03 0.52
Cancer 1,053,491 Disease Target Kallikrein-6 79 35 0.00 -0.75 0.44 0.58
Cancer 1,053,491 Disease Drug Doxercalciferol 80 4 0.00 -0.97 0.05 0.53
Cancer 1,053,491 Disease Target ALPP 80 5 0.00 -0.97 0.06 0.53
Cancer 1,053,491 Disease Target ANGPT1 81 7 0.00 -0.96 0.09 0.54
Cancer 1,053,491 Disease Drug Doxylamine Succinate 81 1 0.00 -0.99 0.01 0.50
Cancer 1,053,491 Disease Target Signal Transducer And Activator Of Transcription 5b 82 13 0.00 -0.92 0.16 0.55
Cancer 1,053,491 Disease Target CAPG 85 25 0.00 -0.84 0.29 0.57
Cancer 1,053,491 Disease Target ENO2 87 15 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target DEP-1 88 7 0.00 -0.96 0.08 0.54
Cancer 1,053,491 Disease Target FABP1 90 13 0.00 -0.92 0.14 0.55
Cancer 1,053,491 Disease Target APO-2L 90 44 0.00 -0.71 0.49 0.58
Cancer 1,053,491 Disease Target Macrophage Metalloelastase 100 15 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target Lanosterol 14 Alpha-Demethylase 101 1 0.00 -1.00 0.01 0.50
Cancer 1,053,491 Disease Target Calcium Dependent Atpase 105 2 0.00 -0.99 0.02 0.51
Cancer 1,053,491 Disease Target Lysosomal Alpha-Glucosidase 105 3 0.00 -0.99 0.03 0.52
Cancer 1,053,491 Disease Target ANGPT2 105 14 0.00 -0.93 0.13 0.55
Cancer 1,053,491 Disease Target Apo D 105 18 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target Ent2 108 8 0.00 -0.96 0.07 0.54
Cancer 1,053,491 Disease Target AACT 109 12 0.00 -0.94 0.11 0.55
Cancer 1,053,491 Disease Target Glutathione S-Transferase A1 111 19 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Drug Alteplase (Activase)- FDA 112 4 0.00 -0.98 0.04 0.52
Cancer 1,053,491 Disease Drug Activase (Alteplase)- FDA 112 4 0.00 -0.98 0.04 0.52
Cancer 1,053,491 Disease Target CXCL10/IP-10 114 10 0.00 -0.96 0.09 0.54
Cancer 1,053,491 Disease Target CALR 117 10 0.00 -0.96 0.09 0.54
Cancer 1,053,491 Disease Target EPHB3 118 25 0.00 -0.89 0.21 0.56
Cancer 1,053,491 Disease Target COP-1 118 2 0.00 -0.99 0.02 0.51
Cancer 1,053,491 Disease Target APOA2 118 9 0.00 -0.96 0.08 0.54
Cancer 1,053,491 Disease Target Acetyl-Coa Carboxylase 1 118 7 0.00 -0.97 0.06 0.53
Cancer 1,053,491 Disease Drug Droloxifene 123 74 0.01 -0.63 0.60 0.59
Cancer 1,053,491 Disease Disease Parkinsons Disease 124 3 0.00 -0.99 0.02 0.52
Cancer 1,053,491 Disease Target APOC1 126 8 0.00 -0.97 0.06 0.54
Cancer 1,053,491 Disease Target ACT-2 127 1 0.00 -1.00 0.01 0.49
Cancer 1,053,491 Disease Target Glutathione Peroxidase 3 132 25 0.00 -0.90 0.19 0.56
Cancer 1,053,491 Disease Target Proteinase-Activated Receptor 1 133 11 0.00 -0.96 0.08 0.54
Cancer 1,053,491 Disease Target FABP3 134 7 0.00 -0.97 0.05 0.53
Cancer 1,053,491 Disease Target 4-1BB Ligand 135 27 0.00 -0.89 0.20 0.56